2,851
edits
Bioavailability: Difference between revisions
→Factors Affecting Bioavailability
| Line 69: | Line 69: | ||
|The fraction of the substance that remains in a bioactive form after metabolic transformations. | |The fraction of the substance that remains in a bioactive form after metabolic transformations. | ||
|Enzymatic activity within the GIT, liver metabolism, systemic circulation, metabolic stability, and enzymatic degradation susceptibility. | |Enzymatic activity within the GIT, liver metabolism, systemic circulation, metabolic stability, and enzymatic degradation susceptibility. | ||
| | |[[Resveratrol]] is rapidly metabolized in the liver into various metabolites, which may have reduced biological activity compared to the parent compound, affecting its overall bioavailability and potential health benefits. | ||
|} | |} | ||